Abstract
We were disappointed by Nora Volkow and George Koob's response to our critique of the brain disease model of addiction (BDMA) from the US National Institute on Drug Abuse (NIDA), which simply repeats the promise of future treatment advances and puts the most favourable spin on modest treatments that have been used since Alan Leshner first promulgated the BMDA in 1997.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
